Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

In a substantial portion of patients (= 25%) with coronary heart disease (CHD), a myocardial infarction or sudden cardiac death without prior symptoms is the first manifestation of disease. The use of new risk predictors for CHD such as the high-sensitivity C-reactive Protein (hs-CRP) in addition to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	GMS health technology assessment 2009-05, Vol.5, p.Doc06-Doc06
Hauptverfasser:	Schnell-Inderst, Petra, Schwarzer, Ruth, Göhler, Alexander, Grandi, Norma, Grabein, Kristin, Stollenwerk, Björn, Klauß, Volker, Wasem, Jürgen, Siebert, Uwe
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!